2 results
Approved WMOPending
To evaluate the efficacy of AD 923 in comparison to MSIR in the management of breakthrough pain in subjects with malignicies who are taking a stable dose of background opioids.
Approved WMORecruiting
To investigate if the use of initial NPWTi leads to a faster wound healing compared to standard wound care only in patients with a POWI.